Evidence map›Paper›PMID 37675509›Full record

ArticleHaematologica2024

Prognostic value of minimal disseminated disease assessed using digital polymerase chain reaction for 3'

Reiji Fukano, Yuka Iijima-Yamashita, Hideto Iwafuchi, Atsuko Nakazawa, Akiko M Saito, Tetsuya Takimoto, Masahiro Sekimizu, Yutaka Suehiro, Takahiro Yamasaki, Shunji Hasegawa and 2 more

Open access · goldAbstract readLetter
In one paragraph

Article in Haematologica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 1 country.

Reiji FukanoDepartment of Pediatrics, Yamaguchi University Graduate School of Medicine, Yamaguchi. fukano.r@yamaguchi-u.ac.jp.
Yuka Iijima-YamashitaClinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya.
Hideto IwafuchiDepartment of Pathology, Shizuoka Children's Hospital, Shizuoka.
Atsuko NakazawaDepartment of Clinical Research, Saitama Children's Medical Center, Saitama.
Akiko M SaitoClinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya.
Tetsuya TakimotoDepartment of Childhood Cancer Data Management, National Center for Child Health and Development, Tokyo.
Masahiro SekimizuDepartment of Pediatrics, National Hospital Organization Nagoya Medical Center, Nagoya.
Yutaka SuehiroDepartment of Oncology and Laboratory Medicine, Yamaguchi University Graduate School of Medicine, Yamaguchi.
Takahiro YamasakiDepartment of Oncology and Laboratory Medicine, Yamaguchi University Graduate School of Medicine, Yamaguchi.
Shunji HasegawaDepartment of Pediatrics, Yamaguchi University Graduate School of Medicine, Yamaguchi.
Tetsuya MoriDepartment of Pediatrics, St. Marianna University School of Medicine, Kanagawa.
Keizo HoribeClinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan; Department of Pediatrics, National Hospital Organization Nagoya Medical Center, Nagoya.
Yamaguchi University · JPNagoya Medical Center · JPNational Hospital Organization · JPNational Center For Child Health and Development · JPSaitama Children's Medical Center · JPShizuoka Children's Hospital · JPSt. Marianna University School of Medicine · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

LymphomaLymphoma, Large-Cell, AnaplasticChildHumansPolymerase Chain ReactionPrognosisReceptor Protein-Tyrosine KinasesReceptor Protein-Tyrosine Kinases

Identifiers

PMID37675509
PMCPMC10828787
OpenAlexW4386506060

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.